● LIVE
NIFTY 5023,980.550.41%BANK NIFTY57,264.151.31%FINNIFTYINDIA VIX11.371.60%NIFTY IT31,352.150.52%NIFTY AUTO28,427.401.44%NIFTY MID14,783.451.63%USD/INR95.20NIFTY 5023,980.550.41%BANK NIFTY57,264.151.31%FINNIFTYINDIA VIX11.371.60%NIFTY IT31,352.150.52%NIFTY AUTO28,427.401.44%NIFTY MID14,783.451.63%USD/INR95.20NIFTY 5023,980.550.41%BANK NIFTY57,264.151.31%FINNIFTYINDIA VIX11.371.60%NIFTY IT31,352.150.52%NIFTY AUTO28,427.401.44%NIFTY MID14,783.451.63%USD/INR95.20
Login
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommoditiesIPOs
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingStartupsEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth

MOREPENLAB

BSE
Morepen Laboratories Limited
Healthcare· Pharmaceuticals & Biotechnology· INE083A01026· Scrip: 500288
ENहिन्दीગુજરાતીमराठी
103.80
3.31 (+0.00%)
2026-09-01
BSE
103.80
3.31
+0.00%
3451698710409-0210-1712-0401-2103-1005-0507-2209-01
197 trading days · 1Y period
TODAY (BSE)
Open107.40
High110.40
Low100.25
Prev Close107.11
Volume13.53L
Value₹14.4Cr
L: 100.25H: 110.40
Info
Face Value₹2
Listed1999-11-24
ISININE083A01026
SeriesB
BSE Scrip500288

Key Metrics

1D
1W
1M
3M
6M
Growth (QoQ)
Revenue+3.44%
PAT-23.42%
EPS-24.62%
Profitability
Dividend
TTM Revenue
₹1699 Cr
TTM EBITDA
₹227 Cr
TTM PAT
₹125 Cr
TTM EPS
₹2.37
Rev/Share
₹31.0

Quarterly Financials

Revenue
EBITDA
PAT
EPS
0 Cr113 Cr226 Cr340 Cr453 Cr22-1223-0323-0923-1224-0324-0624-0924-120.10.20.40.60.50.70.70.5
QuarterRevenueExpensesEBITDAPBTPATEPS
2024-12-31453 Cr423 Cr50 Cr35 Cr27 Cr0.49
2024-09-30438 Cr397 Cr60 Cr46 Cr35 Cr0.65
2024-06-30386 Cr342 Cr51 Cr47 Cr35 Cr0.69
2024-03-31423 Cr385 Cr66 Cr42 Cr28 Cr0.54
2023-12-31445 Cr405 Cr67 Cr44 Cr32 Cr0.63
2023-09-30422 Cr396 Cr44 Cr29 Cr21 Cr0.42
2023-03-31364 Cr356 Cr22 Cr11 Cr8 Cr0.16
2022-12-31348 Cr336 Cr27 Cr14 Cr9 Cr0.15

Shareholding Pattern

CURRENT2026-03-31
35.6%PROMOTER
Promoter35.6%
FII1.6%
DII1.3%
Public64.3%
Govt0.0%
PROMOTER HOLDING TREND
35.6%24-0835.6%24-0935.6%24-1235.6%25-0335.6%25-0935.6%25-1235.6%26-03

Corporate Actions

Ex-DateTypePurpose
2025-08-29DividendDividend - Re 0.20 Per Share
2024-09-20OtherAnnual General Meeting
2023-09-21OtherAnnual General Meeting
2022-09-19OtherAnnual General Meeting
2021-09-20Other Annual General Meeting
2020-09-22Other Annual General Meeting
2019-09-05Other Annual General Meeting
2018-09-12Other Annual General Meeting
2017-09-14Other Annual General Meeting
2016-09-15Other Annual General Meeting
2015-09-10Other Annual General Meeting
2014-09-11OtherAnnual General Meeting
2014-08-08OtherE - Voting
2013-09-05OtherAnnual General Meeting
2012-09-07OtherAnnual General Meeting
2011-09-09OtherAnnual General Meeting
2009-09-11OtherAnnual General Meeting
2008-06-27OtherAnnual General Meeting
2007-08-17OtherAgm
2006-09-18OtherAgm

Earnings Transcripts

Price History

DateOpenHighLowCloseVolume
2026-09-01107.16110.50100.10103.652.47Cr
2026-08-2797.4499.7595.5096.701.46Cr
2026-08-1179.9080.6075.8076.8994.09L
2026-08-1080.7082.0078.1179.161.53Cr
2026-07-2256.8056.8552.9053.2081.97L
2026-07-1760.9061.0057.6658.9077.06L
2026-07-1661.8562.3360.6660.8345.68L
2026-07-1562.9264.5860.7661.241.10Cr
2026-07-1461.8063.6861.5162.561.01Cr
2026-07-1061.6462.9060.5661.2279.60L
2026-07-0959.3163.1059.3160.961.35Cr
2026-07-0860.4862.1958.4258.961.15Cr
2026-07-0760.9062.1758.7161.191.11Cr
2026-07-0360.4060.7558.8159.0794.78L
2026-07-0262.3962.3959.2759.791.43Cr
2026-07-0159.7963.4058.8262.683.97Cr
2026-06-3055.4560.5055.0559.125.35Cr
2026-06-2452.6253.2451.4152.1274.35L
2026-06-1048.9051.8047.7149.374.97Cr
2026-06-0346.0046.1044.1145.4035.85L
2026-05-2742.8042.8041.3842.2274.86L
2026-05-2644.0045.4543.6143.9245.54L
2026-05-2543.4544.0443.0043.7222.82L
2026-05-2243.1944.7942.5142.9139.92L
2026-05-2143.4443.7642.8242.9822.36L
2026-05-2041.4942.9041.1042.5226.75L
2026-05-1941.5042.6341.5041.8620.18L
2026-05-1841.0041.6339.6941.3027.02L
2026-05-1542.7042.9941.8241.9420.13L
2026-05-1444.4544.5542.7043.0129.17L
About

Morepen Laboratories Limited is an Indian pharmaceutical company that develops, manufactures, and markets a range of products including active pharmaceutical ingredients (APIs), generic and branded formulations, and home health products. The company has a strong presence in the Indian market and is recognized for its commitment to quality and innovation in the healthcare sector. Founded in 1992, Morepen Laboratories has established itself as a key player in the pharmaceutical industry.